August 21, 2013

ViiV goes for gold: US premium pricing may threaten dolutegravir use in Europe

On 12 August 2013, the FDA approved dolutegravir in the US. i-Base reported the news with an article linked to previous clinical trial results that noted […]
May 1, 2013

Report from CROI-2013- My Personal Picks

CROI 2013 Report Nelson Vergel I was happy to attend  CROI-2013 in Atlanta on March 3-6, 2013.  These are areas of great interest to me and […]
March 14, 2013

New HIV Drugs and Formulations in the Near Future (CROI 2013 Presentation)

All of the presentations in this section were great. The one on new drugs is contained in the last set of slides (blue slides at 1:22:46) […]
December 17, 2012

Six Promising HIV Drugs in the Pipeline (2013-2014)

By Warren Tong December 5, 2012 Introduction What new HIV medications do we have to look forward to over the next few years? How will these […]